Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.
about
Insulin-like growth factor-1 deficiency and metabolic syndromePre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.Insulin-like growth factor axis and risk of type 2 diabetes in womenThe role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease.Burn injury induces high levels of phosphorylated insulin-like growth factor binding protein-1Hypoxia alters phosphorylation status of insulin-like growth factor (IGF)-binding protein-1 and attenuates biological activities of IGF-I in HepG2 cell cultures.Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma.Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.Kidney growth in normal and diabetic mice is not affected by human insulin-like growth factor binding protein-1 administration.Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis.Non-essential and branched-chain amino acids differentially regulate insulin-like growth factor binding protein-1 production and phosphorylation in HepG2 cells.
P2860
Q28072410-6B5B24E5-0D9E-42A9-82F9-89FCE71BF942Q34577559-DD89E773-1AED-4BB6-9C2B-2758324BF5DCQ35690614-DFA825A3-44CE-4935-85B9-3663F8AFDCA8Q36029231-574B36B4-55BB-49B4-B4ED-D5C93913B21FQ36182551-4143F66C-32D8-44E8-8A0C-67757857C379Q37082951-CE0E3A10-3D48-4694-9690-7B09377C8D4AQ37310264-E429D930-9C2C-4F38-996B-C714678D9BBBQ39132512-9D2D0216-046F-4DC3-9904-6792D6C9E044Q41818701-E1FED402-D323-44A4-B158-B0FFD4C631B4Q42162185-B20E6A90-DA79-4876-A4A5-F165268560B3Q45240140-25F0EE9D-DC18-4005-8B93-092141C01871Q48016290-72681FE0-10D6-483E-93B0-B81E8576B36DQ51022296-5EC078BD-6C1A-44E6-8097-83B8F1F2BC3C
P2860
Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@ast
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@en
type
label
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@ast
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@en
prefLabel
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@ast
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@en
P2093
P356
P1433
P1476
Physiological differences in i ...... on in IGFBP-1 transgenic mice.
@en
P2093
P356
10.2337/DIABETES.50.1.32
P407
P577
2001-01-01T00:00:00Z